1. 90Y‐ibritumomab tiuxetan in patients with extra‐nodal marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma) — The Zeno Study. (13th January 2020) Authors: Lolli, Ginevra; Argnani, Lisa; Broccoli, Alessandro; Marangon, Miriam; Pellegrini, Cinzia; Morigi, Alice; Casadei, Beatrice; Nanni, Laura; Stefoni, Vittorio; Carella, Matteo; Cavo, Michele; Zinzani, Pier L. Journal: British journal of haematology Issue: Volume 189:Number 1(2020) Page Start: e6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 90‐yttrium‐ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high‐risk follicular lymphoma: updated long‐term results after a median follow‐up of 7 years. (14th March 2016) Authors: Casadei, Beatrice; Pellegrini, Cinzia; Pulsoni, Alessandro; Annechini, Giorgia; De Renzo, Amalia; Stefoni, Vittorio; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi Journal: Cancer medicine Issue: Volume 5:Number 6(2016:Jun.) Page Start: 1093 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies. Issue 2 (30th January 2019) Authors: Nanni, Laura; Morigi, Alice; Casadei, Beatrice; Broccoli, Alessandro; Stefoni, Vittorio; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi Journal: Hematological oncology Issue: Volume 37:Issue 2(2019) Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bendamustine‐rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients. Issue 4 (29th July 2020) Authors: Morigi, Alice; Argnani, Lisa; Lolli, Ginevra; Broccoli, Alessandro; Pellegrini, Cinzia; Nanni, Laura; Stefoni, Vittorio; Coppola, Paolo Elia; Carella, Matteo; Casadei, Beatrice; Sabattini, Elena; Cavo, Michele; Zinzani, Pier Luigi Journal: Hematological oncology Issue: Volume 38:Issue 4(2020) Page Start: 487 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia. Issue 1 (15th October 2021) Authors: Broccoli, Alessandro; Terragna, Carolina; Nanni, Laura; Martello, Marina; Armuzzi, Silvia; Agostinelli, Claudio; Morigi, Alice; Casadei, Beatrice; Pellegrini, Cinzia; Stefoni, Vittorio; Sabattini, Elena; Argnani, Lisa; Zinzani, Pier Luigi Journal: Hematological oncology Issue: Volume 40:Issue 1(2022) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effectiveness of chemotherapy after anti‐PD‐1 blockade failure for relapsed and refractory Hodgkin lymphoma. (2nd September 2020) Authors: Casadei, Beatrice; Argnani, Lisa; Morigi, Alice; Lolli, Ginevra; Broccoli, Alessandro; Pellegrini, Cinzia; Nanni, Laura; Stefoni, Vittorio; Coppola, Paolo E.; Carella, Matteo; Cavo, Michele; Zinzani, Pier Luigi Journal: Cancer medicine Issue: Volume 9:Number 21(2020) Page Start: 7830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients. (2nd August 2016) Authors: Gandolfi, Letizia; Pellegrini, Cinzia; Casadei, Beatrice; Stefoni, Vittorio; Broccoli, Alessandro; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi Journal: Oncologist Issue: Volume 21:Number 12(2016) Page Start: 1436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long‐Term Responders After Brentuximab Vedotin: Single‐Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients. (2nd August 2016) Authors: Gandolfi, Letizia; Pellegrini, Cinzia; Casadei, Beatrice; Stefoni, Vittorio; Broccoli, Alessandro; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi Journal: Oncologist Issue: Volume 21:Number 12(2016) Page Start: 1436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real‐life experience. Issue 5 (30th September 2020) Authors: Casadei, Beatrice; Argnani, Lisa; Morigi, Alice; Lolli, Ginevra; Broccoli, Alessandro; Pellegrini, Cinzia; Nanni, Laura; Stefoni, Vittorio; Coppola, Paolo Elia; Carella, Matteo; Cavo, Michele; Zinzani, Pier Luigi Journal: Hematological oncology Issue: Volume 38:Issue 5(2020) Page Start: 737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series. Issue 2 (April 2023) Authors: Broccoli, Alessandro; Argnani, Lisa; Coppola, Paolo Elia; Gentilini, Marianna; Bagnato, Gianmarco; Lolli, Ginevra; Carella, Matteo; Nanni, Laura; Morigi, Alice; Casadei, Beatrice; Pellegrini, Cinzia; Stefoni, Vittorio; Zinzani, Pier Luigi Journal: Tumori Issue: Volume 109:Issue 2(2023) Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗